ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2026
A novel nomogram incorporating LASSO and Cox regression analyses for predicting survival in early-stage non-small cell lung cancer patients following sublobectomy.
Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSublobectomy remains a key surgical approach for stage I non-small cell lung cancer (NSCLC) patients, yet prognostic tools for postoperative outcomes remain scarce. This study developed a nomogram to predict lung-cancer-specific survival (LCSS) following sublobectomy.
methodsWe retrospectively analyzed 8786 early-stage NSCLC patients who underwent sublobectomy between 2005 and 2018 from the SEER database, dividing them into training and validation cohorts. Using LASSO regression to minimize overfitting and address multicollinearity, followed by Cox regression in the training set, we selected final predictors for the nomogram. Model performance was assessed via the C-index, ROC analysis, calibration curves, and DCA, with comparisons made against the 8th TNM staging system and a risk stratification framework.
resultsThe training set comprised 4184 patients, while validation sets A and B included 1794 and 2808 patients, respectively. The nomogram incorporated age, sex, tumor size, grade, surgical approach, and total tumor number. C-index values were 0.70 (training), 0.69 (validation A), and 0.61 (validation B), with 8-year AUCs of 0.698, 0.732, and 0.682, respectively. Calibration curves confirmed strong predictive accuracy, and the nomogram outperformed TNM staging in time-dependent AUC and net benefit on DCA.
conclusionA novel nomogram integrating LASSO and Cox regression reliably predicts long-term LCSS in early-stage sublobectomy patients.
Indexed as
Identifiers
41965480What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.